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Abstract 
In the presence of alcohol, phosphatidylcholine (PC) is transformed to the direct alcohol biomarker 
phosphatidylethanol (PEth). This reaction is catalyzed by the enzyme phospholipase D (PLD) and dependent upon 
substrate availability. As recent methods have solely focused on the determination of PEth, information about the PC 
composition was generally missing. To address this issue and monitor PC (16:0/18:1 and 16:0/18:2) and PEth 
(16:0/18:1 and 16:0/18:2) simultaneously, a reversed phase LC-MS/MS method based on a C8 core-shell column, 
coupled to a Sciex 5500 QTrap instrument was developed. By application of polarity switching, at first, PC was 
measured in ESI positive SRM mode, while PEth was determined at a later stage in ESI negative SRM mode. The  
PEth method was validated for human blood samples to show its robustness and subsequently applied for the 
investigation of systematic in-vitro PEth formation in animal tissue samples (brain, kidney, liver, and blood) from a 
pig, a calf, and a goat. Homogenized tissue was incubated at 37 °C with varying ethanol concentrations from 1-7 
g/kg (determined by HS-GC-FID) for five hours, whereby a sample was taken every 30 minutes. For all tissue 
samples, an increase in PEth was measurable. PEth concentrations formed in blood remained below the LLOQ, in 
agreement with literature. Data analysis of Michaelis-Menten kinetics and PC within the tissue provided a detailed 
insight about PEth formation, as the occurrence of PEth species can be linked to the observed PC composition. The 
results of this study show that PEth formation rates vary from tissue to tissue and among different species. 
Furthermore, new recommendations for PEth analysis are presented.  
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Figure 1Graphical Abstract 
  
Introduction 
As alcohol is one of the most abused substances worldwide, the investigation of consumption behavior by analyzing 
direct alcohol biomarkers has gained vast popularity (1). The analysis is performed during driving aptitude 
assessments (after driving under the influence of alcohol), in child custody cases where one of the parents is 
suspected of alcohol abuse, and to answer various forensic questions, e.g. post-mortem analysis. In comparison to 
state markers (generally used for the assessment of heavy drinking) such as carbohydrate-deficient transferrin (CDT), 
gamma-glutamyl transferase (γ-GT) or the measurement of the mean corpuscular erythrocyte volume (MCV), direct 
alcohol markers have a higher selectivity and specificity (2). By investigation of direct alcohol markers within 
different matrices, evidence of both, short- and long-term consumption can be obtained for high and low doses of 
alcohol. The most promising direct alcohol biomarker to monitor regular alcohol consumption was found in 
phosphatidylethanol (PEth), as the pharmacokinetic characteristics provide a long detection window when compared 
to other direct alcohol biomarkers such as ethyl glucuronide, ethyl sulfate, fatty acid ethyl esters or N-acetyltaurine 
(3-7). Unlike hair analysis, which is generally used for the assessment of drinking behavior over a longer time 
period, PEth determination in blood or organ tissue can serve as an intermediary long term marker without being 
subject to washout effects (8-10). However, a not insignificant drawback for PEth analysis is the instability against 
oxidation and hydrolysis, demanding a short turnover between sampling and analysis (11).  
The phospholipid PEth is formed in the presence of ethanol, by modification of phosphatidylcholine (PC), catalyzed 
by phospholipase D (PLD) (12). Based on the PC substrate availability, PEth 16:0/18:1 and PEth 16:0/18:2 are the 
predominant PEth species generally found in blood and frequently monitored together for abstinence monitoring (1). 
Considering the quantitative analysis of diacyl-glycerophospholipids, Lehmann et al. recently stated that different 
structural isomers of phosphatidylcholine 18:1/18:0 and 18:0/18:1 cause a slightly different fragmentation pattern 
when monitoring the fatty acid chains (13). This is caused by the fact that fragmentation at the SN2 position is 
preferred, which results in a higher signal for the fatty acid chain being present at this position. Therefore special 
attention has to be paid when analyzing PC or PEth samples within various tissues. Dependent on the exact 
composition of the investigated matrix, significant differences between the diacyl-glycerophospholipid 
concentrations (PC and PEth) determined with the quantifier (SRM1) compared to quantification by the use of the 
qualifier (SRM2) are likely to occur (if the transitions are including the fatty acid chain). This is based on the fact 
that the commercially available PC and PEth used for the calibration and the PC and PEth present in the investigated 
tissue do not necessarily contain the same composition of structural isomers. 
In this study, we investigated the in-vitro formation of PEth in the brain, kidney, and liver from a pig, a calf, and a 
goat by systematic incubation with ethanol concentrations from 1-7 g/kg. The goal of the study was to propose and 
demonstrate a procedure to gain a detailed insight into PEth formation in organ tissue. This procedure presents an 
advanced application of the in-vitro incubation to investigate PLD activity, on the base of the study from Schröck et 
al., which focused on PEth formation in human blood (14). The execution of the proposed in-vitro study permits the 
investigation of PEth formation with respect to the presence of both substrates involved in PEth formation, PC and 
ethanol. It may help to explain the high variability of PEth concentrations and compositions observed when 
measuring different tissue samples from post mortem cases (10). It is known, that the PC composition may vary with 
the diet or within different tissues (15-17), however detailed research about PEth formation has been missing so far. 
Kinetic assessments investigating the potential of PEth formation within animal tissue could furthermore provide an 
alternative to in-vivo animal studies, where animals are fed with an alcohol solution for several days and sacrificed 
afterwards (18, 19).  
  
Materials and methods 
Reagents 
Acetonitrile, p.a., was purchased from Acros Organics (Geel, Belgium), isopropyl alcohol, HPLC grade, was 
obtained from Fisher Chemical (Reinach, Switzerland). Phosphatidylcholine 16:0/18:1, 16:0/18:2, and 16:0/18:1-d31 
were purchased from Avanti Polar Lipids, Inc. (Alabaster, USA). Certified spiking solution for phosphatidylethanol 
16:0/18:1 and 16:0/18:2 were purchased from Cerilliant (Round Rock, USA). No information on structural isomers 
was provided by the company. Formic acid, puriss p.a. 98%, phospholipase D from cabbage, and ethanol-d6 (≥99.5 
atom % D) were purchased from Sigma-Aldrich (Buchs, Switzerland). De-ionized water was produced with a Milli-
Q water system from Millipore (Billerica, USA). Ammonium acetate, diethyl ether, calcium chloride, sodium 
chloride, and chloroform were obtained from Merck (Darmstadt, Germany).  
Synthesis of internal standard 
The deuterated internal standards for PEth, 16:0/18:1-d5 and PEth 16:0/18:2-d5, were synthesized as described 
previously (20). Briefly, 10 mg of each PC, 16:0/18:1 and 16:0/18:2, were dissolved in 1.5 mL diethyl ether in 
individual glass vials together with 200 µL ethanol-d6 (≥99.5 atom % D), 200 µg of phospholipase D, and 2.25 mL of 
water containing 100 mM calcium chloride and 100 mM ammonium acetate. The mixtures were shaken for six hours 
at room temperature and stored in the fridge overnight, where phase separation took place. Then the organic phase 
was transferred to a 6 mL glass vial. The remaining aqueous phase was extracted with 1.5 mL diethyl ether three 
times. All the organic phases were collected and evaporated under a stream of nitrogen at 50°C. The white residue 
was dissolved in a 5 mL chloroform/methanol (5:8 v/v) mixture and filtered. The solvent was evaporated 
subsequently. The residue was dissolved in 1 mL chloroform and stored in individual 2 mL crimp-top vials in the 
freezer at about -20°C. For the final PEth internal standard solution 5 µL PEth 16:0/18:2-d5 and 6.6 µL PEth 
16:0/18:1-d5 stock solution were evaporated and reconstituted in 15 mL 2-propanol. To avoid sample contamination 
with remaining educt (PC), the internal standard mixture was tested for remains of PC, by the injection of a 
concentrated internal standard solution into the LC-MS/MS system. With respect to the monitored MRM transitions 
for the specific PC educts, no interfering signals could be detected. Remaining PC residues in the internal standard 
solution would interfere with the simultaneous PC determination in animal tissue since the PC analogs used to 
prepare the PEth IS are identical to the ones determined in animal tissue. 
In-vitro study design 
Animal tissue samples (brain (cerebral cortex), liver, and kidney) from a pig (female, 100 kg, domestic pig, 
selectively bred for meat production by crossing with Duroc pig), a calf (170 kg, male, castrated) and a goat (10 kg) 
were obtained freshly from the butcher (Schlieren, Switzerland) on days of slaughtering. In addition, blood from a 
calf and pooled blood from pigs (n=9) were collected in 9 mL S-monovette tubes containing lithium heparinate to 
prevent coagulation (Sarstedt, Nümbrecht, Germany). Blood from the goat was not available. Approximately 3.5 g of 
tissue sample was weighed into each homogenization tube (n=8) (gentleMacs M Tubes, Macs Miltenyi Biotec, 
Bergisch Gladbach, Germany). Afterwards, 2.5 mL sodium chloride solution (150 mM) was added per gram of tissue 
sample, before homogenization by using a pre-programmed 45 seconds gradient took place (gentle Macs 
Dissociator). Blood samples were used without any dilution (about 7 mL in plastic tubes (13 mL, 100×16 mm, 
Sarstedt, Nümbrecht, Germany)). After one hour in an incubator (Binder, Tuttlingen, Germany) at 37 °C, each 
sample tube (except for the negative control) was spiked with pure ethanol to start the formation of PEth. This 
resulted in alcohol concentrations of about 1, 2, 3, 4, 5, 6 and 7 g/kg (accounting for the total weight of the tissue and 
the solvent, exact ethanol concentrations were determined by HS-GC-FID). The range of spiked alcohol 
concentrations was chosen with respect to the LD50 for rats at 7 g/kg. Samples were subsequently incubated at 37 °C. 
Diluted, homogenized tissue sample (175 µL, accounting for 50 mg of tissue) or 250 µL of blood were taken every 
30 minutes during 5 hours by addition to 2 mL Eppendorf tubes containing 1 mL of acetonitrile each. Prior to every 
sampling, the sample tubes were shaken and vortexed for about 10 seconds (vortex genie, scientific industries, New 
York, USA). In order to quantify PEth, individual calibration samples were prepared in each of the investigated 
matrices and, for external control and PC determination, additionally in solvent. To investigate matrix effects, 
extraction efficiency, and recovery, tissue samples were spiked with PEth at a low (0.15 µg/g) and high (1.5 µg/g) 
concentration (n=3), see Table 6 (supplementary data) (21). 
Determination of alcohol concentration 
After the addition of a previously calculated amount of alcohol from 1 to 7 g/kg, the homogenized animal tissue 
samples from brain, liver, kidney, and blood were analyzed for their individual alcohol concentrations by using 
headspace gas chromatography coupled to a flame ionization detector (HS-GC-FID). Prior to the analysis, the 
samples were diluted by adding water (1:1, w/w) to keep the alcohol concentrations within the calibration range. This 
step was performed by measuring the weight of both added solutions with an analytical balance (AT200, Mettler 
Toledo, Bern, Switzerland). Following this step, the samples were analyzed by using two individual GC-FID systems 
(HP 6890 Series) equipped with two different GC-columns. Each sample was analyzed in duplicate on each system 
(4 measurements in total by using about 110 mg of the sample for each determination), analogously to BAC 
determination in serum, as required by Swiss regulations for forensic BAC determinations (22). Finally, a retrograde 
calculation accounting for the dilution led to the final alcohol concentration. 
Sample preparation for LC-MS/MS measurements 
Protein precipitation, in order to stop any PEth formation after sampling, was performed by adding 1 mL acetonitrile 
to the individual tissue sample (50 mg of tissue), followed by ten seconds of vortexing, see the section in-vitro study 
design. For the subsequent extraction of PEth and PC, 300 µL isopropyl alcohol and 10 µL internal standard solution 
(PEth 16:0/18:1-d5, PEth 16:0/18:2-d5 and PC 16:0/18:1-d31) were added, before the sample was shaken vigorously 
for ten minutes (VXR Vibrax shaker, IKA, Staufen, Germany). Following this step, the samples were centrifuged for 
ten minutes at 16,000 g (Mikro 220R, Hettich, Bäch, Switzerland) before the supernatant was transferred into a 1.5 
mL standard snap-crimp autosampler glass vial and evaporated to dryness under a gentle stream of nitrogen at 50 °C. 
The residue was reconstituted in 400 µL acetonitile/2-propanol/H2O (42:40:18, v/v) and injected into the LC-MS/MS 
system. In order to remain within the calibration range for phosphatidylcholine (which varies between the different 
tissues), different amounts of animal tissue were extracted additionally (25 mg, 12.5 mg, and 6.3 mg, and due to the 
high PC content, for brain additionally 2.85 mg and 1.43 mg). 
  
LC-MS/MS analysis for phosphatidylcholine and phosphatidylethanol 
The concentration of the main PEth precursor molecules, PC 16:0/18:1 and PC 16:0/18:2, and the two most abundant 
analogs of phosphatidylethanol, PEth 16:0/18:1 and PEth 16:0/18:2, were determined by liquid chromatography, 
tandem mass spectrometry (LC-MS/MS) by using the same method for all the analytes, see Figure 2. In order to 
obtain a chromatographic separation, a reversed phase Kinetex core-shell C8 column, 2.6 µm, 100 Å, 100 x 2.1 mm 
(Phenomenex, Torrance, USA), on an UltiMate® 3000 UHPLC system (Dionex, Thermo Scientific Instruments, 
Reinach, Switzerland) was used. The analytes were separated with a flow rate of 0.3 mL/min at 60 °C (reaching an 
operating pressure of about 180-300 bar). Gradient elution was performed with 70:30 (v/v) acetonitrile/water with 
0.1% formic acid (A) and pure isopropyl alcohol (B): 0-1 min: 40% B; 1-7 min: 40% B to 80% B; 7.1-8.5 min 99% 
B; 8.5-10 min 40% B. By using the six port valve system of the LC system, the flow was directed into the waste 
during the first 4 minutes to minimize potential contamination of the mass spectrometer (5500 QTRAP, Sciex, 
Toronto, Canada). Afterwards, the valve was switched to direct the flow to the mass spectrometer, which was 
operated in electrospray positive mode with selected reaction monitoring (SRM) for PC determination: ion spray 
voltage at 2000 V, source temperature of 500 °C, collision gas at medium, curtain gas at 30, gas 1 at 15, gas 2 at 20, 
and a cycle time of 0.200 s (arbitrary units). After 5.85 minutes the mass spectrometer was switched to the 
electrospray negative mode for the determination of PEth: ion spray voltage at -4250 V, source temperature of 500 
°C, collision gas at medium, curtain gas at 30, gas 1 at 15, gas 2 at 20, and a cycle time of 0.2501 s (arbitrary units). 
For MS/MS parameters, see Table 1.  
Table 1.- Mass spectrometric parameters and retention times for phosphatidylcholine and 
phosphatidylethanol determination. Q1=parent ion, Q3= fragment ion, DP= declustering potential, CE= 
collision energy, CXP=cell exit potential, RT=retention times. 
Compound Q1 
[m/z] 
Q3 
[m/z] 
Dwell time 
[msec] 
DP 
[volts] 
CE 
[volts] 
CXP 
[volts] 
RT 
[min] 
PC 16:0/18:1 SRM1 760.6 124.8 20 14 111 7 5.72 PC 16:0/18:1 SRM2 760.6 184.1 20 11 37 11 
PC 16:0/18:1–d31 SRM1 791.7 184.1 20 5 45 42 5.63 PC 16:0/18:1–d31 SRM2 791.7 791.7 20 7 15 40 
PC 16:0/18:2 SRM1 758.3 125.3 20 10 94 9 5.46 PC 16:0/18:2 SRM2 758.3 184.1 20 10 40 9 
polarity switch from 2000 V to -4250 V at 5.85 minutes 
PEth 16:0/18:1 SRM1 701.3 255.2 20 -32 -40 -14 6.36 PEth 16:0/18:1 SRM2 701.3 281.3 20 -20 -40 -14 
PEth 16:0/18:1–d5 SRM1 706.3 255.3 20 -20 -40 -14 6.34 PEth 16:0/18:1–d5 SRM2 706.3 281.1 20 -32 -40 -14 
PEth 16:0/18:2 SRM1 699.5 279.4 20 -5 -40 -14 6.10 PEth 16:0/18:2 SRM2 699.5 255.3 20 -5 -40 -14 
PEth 16:0/18:2–d5 SRM1 704.5 279.5 20 -5 -40 -14 6.08 PEth 16:0/18:2–d5 SRM2 704.5 255.3 20 -5 -40 -14 
 Figure 2 Detailed chromatograms for PC and PEth determination within kidney tissue, spiked with 5 g/kg of 
ethanol. 
a.) total ion chromatogram for a kidney sample, the polarity switch at 5.85 min is indicated with a bar.  
b.) extracted ion chromatogram for PC 16:0/18:2 (758.3125.3 blue, 758.3184.1 red) and PC 16:0/18:1 
(760.6124.8 green, 760.6184.1 grey). 
c.) extracted ion chromatogram for PEth 16:0/18:2 (699.5279.4 blue, 699.5 255.3 red) and PEth 16:0/18:1 
(701.3281.3 green, 701.3255.2 grey) with the respective internal standard (704.5279.5 light blue, 
704.5255.3 pink, 706.3281.1 mint, 706.3255.3 purple) 
  
Data processing for phosphatidylcholine and phosphatidylethanol determination 
Phosphatidylethanol concentrations were corrected for the amount of PEth 16:0/18:1 (74.4%) and PEth 16:0/18:2 
(74.2%) within the certified spiking solution from Cerilliant, which was delivered as tetra-N-butylammonium salt. 
Ionization differences and losses during sample preparation were corrected by the addition of the respective internal 
standards, PEth 16:0/18:1-d5 and PEth 16:0/18:2-d5, by dividing the area of the analyte signal by the area of the 
respective internal standard signal. For the quantification of phosphatidylcholine only one internal standard, PC 
16:0/18:1-d31, was used for both analytes (the use of the initially intended PC 17:0/17:0 proved to be unsuitable due 
to interferences). The mean of the concentrations determined with the two monitored SRM transitions, representing 
different fatty acids as product ions: m/z 255.2 for the palmitate (16:0), 281.3 for the oleate (18:1), and 279.4 for the 
linoleate (18:2), was taken into account for different positional isomers of PEth. The ratios of the product ion 
intensities vary slightly, depending on the distribution of the fatty acid chains at the SN1 or SN2 position. 
Chromatographic baseline separation of these positional isomers is not possible. We investigated quantification 
differences between SRM1 and SRM2 in samples from organ tissues, (PEth 16:0/18:1 vs. PEth 18:1/16:0 and PEth 
16:0/18:2 vs. PEth 18:2/16:0) however, not in spiked samples (as the ratio within the reference solution remains 
constant). To normalize these differences to the reference solution, we decided to report the mean concentration of 
both transitions as final concentration throughout the manuscript. However, the exact distribution within the 
reference solution remains unknown. Experimental details about the occurrence of this issue are provided in the 
results and discussion section. For the quantification of PCs, where fragment ions containing the polar head group 
were monitored, we agreed to report the mean of both transitions as well. 
Phosphatidylcholine and phosphatidylethanol method validation 
PC concentrations were determined by using a seven-point calibration (0.5-100 µg/mL) and three quality control 
samples (1, 3, 75 µg/mL) in solvent. The LLOQ was set at 1 µg/mL, the LOD at 0.2 µg/mL. PEth concentrations 
were determined with a seven-point calibration (0.0075-1.5 µg/mL) and four quality control samples (0.0075, 0.015, 
0.045, 1,125 µg/mL) prepared in blood from an abstinent subject (250 µL of blood, no PEth detectable). The LLOQ 
was set at 0.0075 µg/mL, the LOD at 0.0035 µg/mL. Sample preparation was performed as described in the section 
sample preparation for LC-MS/MS measurements. For method validation, three series of six samples at each quality 
control concentration were prepared and analyzed on three different days by using two calibration series, according 
to FDA guidelines (23). According to these guidelines, the mean value for accuracy and imprecision for quality 
control samples (n=6), during each series (intra-assay) and among three series (inter-assay) has to be within ±15% of 
the actual value, except at the limit of quantification (LLOQ), where a deviation up to ±20% is accepted. Extraction 
efficiency, recovery, and matrix effects were investigated quantitatively (in triplicate) according to Matuszewski for 
each tissue sample at a low and a high concentration (0.04 µg/mL and 0.5 µg/mL). (21). The recovery, extraction 
efficiency, and matrix effect for PC could not be investigated, as PC represents an endogenous substance which is 
present in high concentrations in blood. However, by performing series of dilution for each tissue, no significant 
effect considering concentration differences could be observed. For blood samples, an amount of 2 µL was injected. 
For calibration samples in solvent, 0.4 µL was injected into the LC-MS system. 
Isomer specific fragment ion abundances of PEth 
In order to show the effect of isomer specific fragmentation occurring for diacyl-glycerophospholipids such as PEth, 
when monitoring acyl fragments, the individual concentrations of PEth, obtained from the two monitored SRM 
transitions (>LLOQ), were compared by the mean observed concentration. Therefore the concentration determined 
with the SRM transition which monitors SRM1 (product ion with m/z 255 (palmitate (16:0)) was divided by the 
quantitative result with SRM 2 (product ion with m/z 281.3 (oleate (18:1)) or 279.4 (linoleate (18:2))).  
Results and Discussion 
Validation Results for PC and PEth 
During method validation, the observed calibration linearity was >0.9968 for PC 16:0/18:1 and >0.9956 for PC 
16:0/18:2, by using a weighted calibration (1/x). Intra-assay accuracy and precision, determined by measuring six 
samples of each quality control sample (series 1) were determined to be 93-105% and 1.8-4.0 %CV for PC 
16:0/18:1, and 95-111% and 2.1-7.5 %CV for PC 16:0/18:2, respectively. Inter-assay accuracy and precision for 
three series with six measurements in each series (n=18) were 95.6-104.4% and 3.2-4.7 %CV for PC 16:0/18:1, and 
99.2-108.6% and 4.8-7.0 %CV for PC 16:0/18:2, respectively.  
The observed calibration linearity during method validation was >0.9981 for PEth 16:0/18:1, and >0.9983 for PEth 
16:0/18:2, by using a weighted calibration (1/x). Intra-assay accuracy and precision (series 1), determined by 
measuring six samples of each quality control sample were determined to be 93-107% and 3.1-8.9 %CV for PEth 
16:0/18:1, and 91-111% and 4.4-8.0 %CV for PEth 16:0/18:2, respectively. Inter-assay accuracy and precision for 
three series with six measurements in each series (n=18) were 95.9-102.8% and 4.2-7.2 %CV for PEth 16:0/18:1, 
and 94.8-109.8% and 4.2-6.9 %CV for PEth 16:0/18:2, respectively. The observed matrix effects for PEth are 
presented in Table 2. With respect to the obtained validation data for PC and PEth, the method fulfills the criteria for 
accuracy and precision of the FDA guidelines. 
Table 2 Recovery, extraction efficiency, and matrix effects for blood samples spiked with a low and a high 
concentration of PEth (0.04 µg/mL and 0.5 µg/mL). The data represents the mean of SRM1 and SRM2, by 
taking the mean out of three measurements at each concentration, in each tissue. 
 16:0/18:1 low 16:0/18:1 high 16:0/18:2 low 16:0/18:2 high 
recovery 77% 74% 80% 79% 
extraction efficiency 75% 80% 78% 91% 
matrix effects 102% 93% 102% 88% 
  
PC concentration in tissue samples 
Brain 
From all tissue samples, the brain tissue showed the highest phosphatidylcholine concentrations for the investigated 
PCs, being responsible for 11.5% (calf) and 13.0% (goat & pig) of the total brain mass (moist mass). In order to be 
within the PC calibration range, low amounts of the sample had to be measured by using just 1.43 mg or 2.85 mg of 
homogenized tissue. A comparison between PC 16:0/18:1 and PC 16:0/18:2 showed that PC 16:0/18:2 accounts for 
only 3.95% (pig), 4.31% (calf), and 4.95% (goat) of the total mass of both substances. This results in a narrow ratio 
for all the species for PC 16:0/18:2 to PC 16:0/18:1 of 4.1-5.2%, indicating that PC 16:0/18:1 is the main substrate 
for PEth formation in the brain. For a detailed comparison refer to Table 3. 
Liver 
Among the three tested species, the liver tissue showed the highest variability in phosphatidylcholine concentrations. 
The measured PC concentrations accounted for 5.0% (calf), 6.0% (goat), and 8.6% (pig) of the total tissue mass. The 
observed amounts for PC 16:0/18:1 were 3.5% (calf), 4.1% (goat), and 4.9% (pig). PC 16:0/18:2 was responsible for 
a share of 1.4% (calf), 1.9% (goat), and 3.8% (pig). This results in a ratio of PC 16:0/18:2 to PC 16:0/18:1 of 40-
78%. For the calf, the liver was the organ with the lowest amount of total PC. For a detailed comparison refer to 
Table 3. 
Kidney 
PC 16:0/18:1 and PC 16:0/18:2 concentrations in kidney were responsible for 5.2% (goat), 6.0% (calf), and 6.3% 
(pig) of the total mass. Among the three observed organs, the kidney showed the lowest amount of 
phosphatidylcholine for the pig and the goat. The observed amount of PC 16:0/18:1 within the kidney was close to 
each other, by accounting for 3.4% (pig), 3.5% (goat) and 3.6% (calf) of the total mass. The percentage of PC 
16:0/18:2 however, showed a higher variability, being responsible for 1.7% (goat), 2.3% (calf), and 2.9% of the total 
mass. This results in a ratio of PC 16:0/18:2 to PC 16:0/18:1 of 48-85%. For a detailed comparison refer to Table 3. 
Blood 
The investigated blood samples from pig and calf showed the lowest amount of PC by weight when compared to 
organ tissue. Pig blood showed almost equivalent amounts of PC 16:0/18:1 and PC 16:0/18:2 at 89 µg/mL and 81.5 
µg/mL, respectively. This accounts for 0.009% and 0.008% of the total weight. In the blood of the calf, 
concentrations of 28 µg/mL for PC 16:0/18:1 and 102 µg/mL for PC 16:0/18:2 were measured, resulting in a ratio of 
PC 16:0/18:2 to PC 16:0/18:1 of 356%. 
Table 3 Percentage of measured PC concentration within the sample for PC 16:0/18:1, PC16:0/18:2 and the 
sum (total mass) of both PC concentrations. Figures displayed here are rounded. 
 
PC 16:0/18:1 PC 16:0/18:2 total mass 
Ratio 
(16:0/18:2)/(16:0/18:1) 
Pig 
Brain 12.5% 0.5% 13.0% 4.1% 
Kidney 3.4% 2.9% 6.3% 85.5% 
Liver 4.9% 3.8% 8.6% 77.5% 
Calf 
Brain 11.0% 0.5% 11.5% 4.5% 
Kidney 3.6% 2.3% 6.0% 63.8% 
Liver 3.5% 1.4% 5.0% 40.4% 
Goat 
Brain 12.3% 0.6% 13.0% 5.2% 
Kidney 3.5% 1.7% 5.2% 48.2% 
Liver 4.1% 1.9% 6.0% 45.3% 
 
PEth concentration of tissue samples 
Brain 
For the calf and pig brain, a saturation curve for PEth formation could be observed, see Figure 3. A Lineweaver-Burk 
plot revealed a Vmax of 0.67 µmol*h-1*kg-1 with a Km of 1.74 g/kg (calf), and a Vmax of 1.38 µmol*h-1*kg-1 with a Km 
of 5.20 g/kg (pig) for the formation of PEth 16:0/18:1. For the formation of PEth 16:0/18:2, a Vmax of 0.023 µmol*h-
1*kg-1 with a Km of 0.90 g/kg (calf), and a Vmax of 0.044 µmol*h-1*kg-1 with a Km of 2.22 g/kg (pig) was observed. 
Based on these results, the formation of PEth in calf brain appears to reach saturation at lower concentrations, when 
compared to the pig sample. The observed formation rates for PEth in goat brain tissue varied heavily from 5-7 g/kg, 
which did not result in an ambiguous saturation curve. Formation rates of up to 3 µmol*h-1*kg-1 for PEth 16:0/18:1 
and up to 0.12 µmol*h-1*kg-1 for PEth 16:0/18:2 were observed in goat brain samples. The subsequent analysis of the 
second sample taken at every time point confirmed this observation. Observable for all brain samples was a large 
increase in PEth 16:0/18:1 over time, while PEth 16:0/18:2 was formed at a much lower rate (4.1-5.5% PEth 
16:0/18:2, when compared to PEth 16:0/18:1). This observation can be explained by observing about the same 
difference in substrate availability, see the section PC concentration in brain samples. For a detailed comparison 
please have a look at Table 4. 
 
Figure 3 Formation rates of PEth 16:0/18:1 and PEth 16:0/18:2 in brain tissue from a goat, a pig, and a calf. 
Liver 
For all PEth formation rates observed in the different liver tissue samples at different alcohol concentrations, a 
Lineweaver-Burk plot was performed, which resulted in the following formation rates for PEth 16:0/18:1: a Vmax of 
0.256 µmol*h-1*kg-1 with a Km of 2.96 g/kg (goat), a Vmax of 0.316 µmol*h-1*kg-1 with a Km of 3.74 g/kg (calf), and 
a Vmax of 0.172 µmol*h-1*kg-1 with a Km of 5.63 g/kg (pig), see Figure 4. For PEth 16:0/18:2 however, the following 
rates were observed: a Vmax of 0.102 µmol*h-1*kg-1 with a Km of 2.18 g/kg (goat), a Vmax of 0.097 µmol*h-1*kg-1 
with a Km of 2.11 g/kg (calf), and a Vmax of 0.143 µmol*h-1*kg-1 with a Km of 4.4 g/kg (pig). The pig liver tissue 
seems to have a lower formation rate for PEth. With respect to PEth 16:0/18:2 this seems to be compensated by 
about twice the amount of the relative PC substrate within the tissue, resulting in about the same formation rate as 
goat or calf tissue, see the section PC concentration in liver samples. For a detailed comparison please have a look at 
Table 4. 
 
Figure 4 Formation rates of PEth 16:0/18:1 and PEth 16:0/18:2 in liver tissue from a goat, a pig, and a calf. 
  
Kidney 
The observed formation rates for kidney tissue in samples from goat and calf were similar, this resulted in a 
Lineweaver-Burk plot with the following results: Vmax of 1.25 µmol*h-1*kg-1 with a Km of 5.74 g/kg (calf), Vmax of 
1.18 µmol*h-1*kg-1 with a Km of 6.0 g/kg (goat) for PEth 16:0/18:1, see Figure 5. For PEth 16:0/18:2 a Vmax of 0.96 
µmol*h-1*kg-1 with a Km of 5.60 g/kg (calf) and a Vmax of 0.92 µmol*h-1*kg-1 with a Km of 6.90 g/kg (goat) was 
observed. The pig kidney, however, showed lower rates, with a Vmax of 0.318 µmol*h-1*kg-1 with a Km of 4.4 g/kg 
(pig) for PEth 16:0/18:1 and Vmax of 0.36 µmol*h-1*kg-1 with a Km of 5.6 g/kg (pig) for PEth 16:0/18:2. For a 
detailed comparison please have a look at Table 4. 
 
Figure 5 Formation rates of PEth 16:0/18:1 and PEth 16:0/18:2 in kidney tissue from a goat, a pig, and a calf. 
  
Table 4 Kinetic parameters obtained for Peth 16:0/18:1 and PEth 16:0/18:2 in the course of this study. 
 
PEth 16:0/18:1 PEth 16:0/18:2  
Vmax 
µmol*h-1*kg-1 
Km 
g/kg 
Vmax 
µmol*h-
1*kg-1 
Km 
g/kg 
Ratio Vmax 
Vmax(16:0/18:2)/Vmax(16:0/18:1) 
Pig 
Brain 1.38 5.20 0.044 2.22 3% 
Kidney 0.318 4.4 0.36 5.6 113% 
Liver 0.172 5.63 0.143 4.4 83% 
Calf 
Brain 0.67 1.74 0.023 0.9 3% 
Kidney 1.25 5.74 0.96 5.60 77% 
Liver 0.316 3.74 0.097 2.11 31% 
Goat 
Brain No reliable data 
Kidney 1.18 6.0 0.92 6.90 78% 
Liver 0.256 2.96 0.102 2.18 40% 
  
Blood 
The formation of PEth in blood from pig and calf remained below the limit of quantitation, supporting the 
observation of Viel et al. that human red blood cells seem to be peculiar in forming PEth in-vitro in the presence of 
ethanol (24). 
Comparison between PC and PEth composition and the ratio of Vmax 
A comparison between the measured PC 16:0/18:2 to PC 16:0/18:1 ratio and the measured PEth 16:0/18:2 to PEth 
16:0/18:1 ratio indicates a relationship between substrate availability and product formation, see Figure 6. Especially 
for all the brain samples, as well as calf liver and goat liver, the substrate ratio closely reflects the observed PEth 
ratio (differences of 0-3%). Pig liver showed a higher difference (15%). For kidney samples, larger discrepancies 
were measured for all animal species (differences of 14-21%). Based on this observation, the formation of PEth in 
kidney tissue could be influenced by other factors than just substrate availability. 
Comparing the ratio between the measured PEth 16:0/18:2 and PEth 16:0/18:1 concentration with the ratio obtained 
for maximum velocity between PEth 16:0/18:2 and PEth 16:0/18:1, we can see that there is a strong link between the 
directly observable PEth ratio and the obtained kinetic parameters. 
 
Figure 6 Comparison between the PC ratio ((16:0/18:2)/(16:0/18:1)), the PEth ratio ((16:0/18:2)/(16:0/18:1)), 
and the Vmax ratio ((16:0/18:2)/(16:0/18:1)) in the different animal tissue samples. For the PEth ratio, the mean 
of the observed ratios for all series (1 to 7 g/kg of ethanol) after 5 hours incubation time is represented. 
Isomer specific fragment ion abundances of PEth 
Contrary to spiked quality control samples in tissue, produced with the same PEth solutions as the calibration curves, 
samples containing PEth produced by in-vitro formation from endogenous PC showed differences in the 
quantification results when quantifying with either SRM1 or SRM2 as the only quantifier. We therefore decided to 
report the PEth concentrations as the mean concentration of both SRM transitions as final concentration throughout 
the manuscript (previously mentioned in the material and methods section). Especially brain samples show elevated 
ratios from 126-138%. Detailed information about the differences in ratios obtained in tissue samples is displayed in 
Table 5 (PEth 16:0/18:1). 
Caution has to be taken with the interpretation of this data, as the observed ratio is dependent on the composition 
(positional isomer distribution) of the reference solution used for the generation of the calibration. Reference 
solutions from a different manufacturer might lead to different ratios. 
Table 5 The concentration determined with the SRM transition which monitors SRM1 (product ion with m/z 
255 (palmitate (16:0)) was divided by the quantitative result with SRM 2 (product ion with m/z 281.3 (oleate 
(18:1)) or 279.4 (linoleate (18:2))). The here presented data shows the ratio. 
 Brain Liver Kidney 
Calf 135% 104% 102% 
Goat 138% 117% 119% 
Pig 126% 119% 136% 
Human blood (spiked 
QC from validation) 
100% 
 
Conclusion 
The simultaneous measurement of PC and PEth provides additional information, as the substrate concentration (PC) 
influences the formation of the product (PEth). This can help to explain differences in PEth concentrations between 
various tissues. For example the observation of Thompson et al., that PEth 16:0/18:1 levels were about 10-fold 
higher than PEth 16:0/18:2 in all subjects and both areas of human brain (cerebellum and orbital frontal cortex), is 
very likely based on a PC ratio within the human brain which is similar to the PC distributions observed in this study 
for goat, pig, and calf brain (10). Considering the significance of the results, it should be kept in mind, that only one 
individual of each species was investigated during this study.  
By having low concentrations of PC within the sample, the newly developed method is able to determine the 
analytes, PC and PEth, within one run, making it an ideal tool to assess PC and PEth distributions within the blood. 
This may find an application in the study of communities with different nutritional habits. A disadvantage for the 
accuracy of PC determination is however the omnipresence of PC within biological samples. To address this issue, a 
solvent based calibration is required, which does not account for potential matrix effects. 
Considering the formation of PEth, the presented methodology was able to show increasing PEth formation rates 
with increasing ethanol concentrations in eight out of nine cases. The sample homogeneity when working with tissue 
samples appeared to be a crucial issue, as high variation in PEth formation rates were observed in goat brain, which 
was the smallest brain observed in this study. The need for a large amount of sample from a single, small organ 
appeared to be challenging. We therefore recommend the use of animals with larger organs for the investigation of 
in-vitro formation, as it is easier to obtain large amounts of specific samples (e.g. cerebral cortex). Furthermore, we 
recommend the analysis of several samples from different organs when performing PEth determination in post-
mortem samples. In our case, Vmax and Km values evaluated by Michaelis-Menten kinetics showed a large variation 
between different organs and different species. If these differences are caused by different PLD isoforms or just 
varying PLD concentrations within the tissue remains unknown. Different isozymes of PLD, which could be 
responsible for this observation, have been identified and an organ-specific distribution of PLD isozymes was 
demonstrated by earlier investigations (25-27). with respect to this issue, the group of Arradotir et al. investigated rat 
organs after ethanol exposure and stated that variations in PEth levels, the rate of PEth formation, and the PEth 
degradation are organ specific, which is supported by our findings (19). To prevent the post sampling formation of 
PEth in organ tissue observed by Arradotir et al., we recommend immediate homogenization and subsequent storage 
in a solvent such as acetonitrile, to precipitate any PLD (9). Additionally, we recommend the inclusion of transitions 
for both fatty acid chains within the method to observe and correct isomer specific fragment ion abundances. 
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Table 6 recovery, extraction efficiency, matrix effect for the investigated tissue samples, investigated at a low 
and high PEth concentration (0.15 µg/g and 1.5 µg/g). The data represents the mean of SRM1 and SRM2, by 
taking the mean out of three measurements at each concentration, in each tissue. 
 
recovery extraction efficiency matrix effect 
PEth 16:0/18:1 PEth 16:0/18:2 PEth 16:0/18:1 PEth 16:0/18:2 PEth 16:0/18:1 PEth 16:0/18:2 
pig 
liver low 91% 93% 86% 85% 106% 109% 
liver high 75% 78% 78% 84% 96% 93% 
kidney low 108% 111% 95% 92% 113% 121% 
kidney high 84% 90% 86% 93% 97% 97% 
brain low 118% 94% 92% 83% 130% 114% 
brain high 63% 71% 72% 79% 87% 90% 
calf 
liver low 84% 99% 76% 86% 111% 116% 
liver high 76% 84% 80% 85% 95% 98% 
kidney low 86% 104% 83% 84% 103% 123% 
kidney high 79% 89% 80% 87% 100% 102% 
brain low 106% 98% 83% 91% 127% 108% 
brain high 64% 78% 67% 82% 96% 95% 
goat 
liver low 84% 101% 78% 89% 109% 113% 
liver high 74% 80% 76% 83% 97% 96% 
kidney low 115% 118% 86% 99% 132% 119% 
kidney high 73% 82% 74% 83% 99% 99% 
brain low 116% 108% 83% 98% 140% 110% 
brain high 65% 74% 71% 80% 92% 93% 
 
